We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AMCAL MOMETASONE ALLERGY RELIEF NASAL SPRAY mometasone furoate (as monohydrate) 50 mcg/actuation suspension bottle, Neo Health OTC Pty Ltd, CON-1127
Product name
AMCAL MOMETASONE ALLERGY RELIEF NASAL SPRAY mometasone furoate (as monohydrate) 50 mcg/actuation suspension bottle
Sponsor name
Neo Health OTC Pty Ltd
Consent start
Consent no.
CON-1127
Duration
The consent is effective from 12 July 2023 until 31 December 2023.
Standard
paragraph 8(1)(k) of Therapeutic Goods Order No. 92 - Standard for labels of non-prescription medicines
Non-compliance with standard
The labels do not include certain required warning statements specified in the
Therapeutic Goods (Medicines Advisory Statements) Specification 2021 (RASML No.
6).
Import, Supply, &/or Export
import and supply
Therapeutic product type
Over-the-counter medicines